Mebea Aklilu

1.1k citations
28 papers · 847 indexed · h-index 14
Topics
Cancer Immunotherapy and Biomarkers (7 papers)Immunotherapy and Immune Responses (7 papers)Colorectal Cancer Treatments and Studies (6 papers)
Journals
Journal of Clinical OncologySHILAP Revista de lepidopterologíaCancer

In The Last Decade

Mebea Aklilu

28 papers receiving 827 citations

Peers

Mebea Aklilu
Comparison fields: 5 of 82
  • Oncology 494
  • Pulmonary and Respiratory Medicine 265
  • Immunology 212
  • Molecular Biology 203
  • Surgery 176
Replace Karim Rihawi with:
Karim Rihawi Italy
Philipp Manegold United States
Laura M. Rosenberg United States
Qijia Xuan China
Hidenori Akaike Japan
Constantijne H. Mom Netherlands
Arjan Kol Netherlands
Daria Arbogast United States
Koichi Okamoto Japan
Joo‐Shik Shin Australia
Mebea Aklilu relative to Karim Rihawi Italy Karim Rihawi's profile →
Citations per field
00.5×1.6×
Karim Rihawi · 1×
Citations per year

Countries citing papers authored by Mebea Aklilu

Since Specialization
Citations

This map shows the geographic impact of Mebea Aklilu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mebea Aklilu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mebea Aklilu more than expected).

Fields of papers citing papers by Mebea Aklilu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mebea Aklilu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mebea Aklilu. The network helps show where Mebea Aklilu may publish in the future.

Co-authorship network of co-authors of Mebea Aklilu

This figure shows the co-authorship network connecting the top 25 collaborators of Mebea Aklilu. A scholar is included among the top collaborators of Mebea Aklilu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mebea Aklilu. Mebea Aklilu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 36
2 9
3 3
4 33
5 107
6 7
7 6
8 13
9 1
10 73
11
A phase II study of capecitabine, oxaliplatin, bevacizumab and cetuximab in the treatment of metastatic colorectal cancer.
23
12 38
13 3
14 19
15 12
16 50
17 4
18 2
19 89
20 20

About Mebea Aklilu

Mebea Aklilu is a scholar working on Oncology, Immunology and Hepatology, having authored 28 papers that have together received 847 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Immunotherapy and Immune Responses (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). The work is most often cited by research in Oncology (494 citations), Immunology (212 citations) and Pulmonary and Respiratory Medicine (265 citations). Mebea Aklilu has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Cathy Eng, Hedy L. Kindler, Everett E. Vokes, Ross C. Donehower, Garth H. Rauscher, Ajay V. Maker, Leigh Casadaban, Sridhar Mani, Sally Freels and Walter M. Stadler. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026